Doctor profile · Federal record
Dr. Arshad Khanani, M.D.
Ophthalmology Physician (CMS: Ophthalmology) · Reno, NV
- NPI 1295929511
- Accepts Medicare
- MIPS 72.7 / 100 · 2023
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
950 Ryland St
Reno, NV 89502
(775) 329-0286
fax (775) 329-4243
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- December 7, 2010
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Nevada #13420
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295929511. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
159,700
Distinct HCPCS
10
Medicare allowed
$8,253,007
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 140,940 | 376 | $36 | |
92134 |
Imaging of retina | 4,809 | 1,448 | $40 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 4,170 | 194 | $224 | |
67028 |
Injection of drug into eye | 3,205 | 624 | $125 | |
92014 |
Established patient complete exam of visual system | 1,978 | 1,246 | $124 | |
J2779 |
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg | 1,500 | 12 | $80 | |
J0178 |
Injection, aflibercept, 1 mg | 1,008 | 126 | $853 | |
92012 |
Established patient problem focused exam of visual system | 960 | 509 | $89 | |
J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg | 357 | 18 | $199 | |
92250 |
Photography of the retina | 246 | 205 | $36 |
In context: peer comparison
Among 13 peers in Reno Ophthalmology Physician, average services per provider: 1,166. This provider delivers 137× the peer median.Open Payments
Industry payments received
All-time total
$302,441
Transactions
171
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ocular Therapeutix, INC. | 48 | $81,101.82 | |
| F. Hoffmann-la Roche Ag | 25 | $80,674.94 | |
| Abbvie INC. | 21 | $51,732.37 | |
| Genentech, INC. | 5 | $17,533.94 | |
| Genentech USA, INC. | 29 | $14,892.52 | |
| Sanofi US Services INC. | 2 | $9,765.00 | |
| Alcon Vision LLC | 2 | $9,000.00 | |
| Amgen INC. | 3 | $8,400.00 | |
| Astellas Pharma US INC | 19 | $5,939.01 | |
| Astellas Pharma Global Development | 1 | $4,800.00 | |
| Apellis Pharmaceuticals, INC. | 3 | $3,292.42 | |
| Regeneron Healthcare Solutions, INC. | 4 | $3,221.00 | |
| Boehringer Ingelheim International GmbH | 3 | $2,900.00 | |
| EyePoint Pharmaceuticals US, INC. | 2 | $2,000.00 | |
| Harrow Eye, LLC | 4 | $1,630.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
425
Patients
197
Total drug cost
$57,355
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 107 | 73 | $6,958 |
| Timolol Maleate | Generic | 45 | 20 | $874 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 43 | 17 | $1,005 |
| Latanoprost | Generic | 40 | 17 | $793 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 37 | 21 | $673 |
| Difluprednate | Generic | 22 | 11 | $3,339 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 20 | 0 | $10,100 |
| Restasis (Cyclosporine) | Brand | 20 | 0 | $28,395 |
| Ketorolac Tromethamine | Generic | 18 | 12 | $464 |
| Brimonidine Tartrate | Generic | 16 | 0 | $301 |
Frequently asked questions
What is Dr. Arshad Khanani's medical specialty?
Dr. Arshad Khanani practices Ophthalmology Physician in Reno, NV.
Where does Dr. Arshad Khanani practice?
Dr. Arshad Khanani practices at 950 Ryland St, Reno, NV 89502. Office phone: 7753290286.
What is Dr. Arshad Khanani's NPI?
Dr. Arshad Khanani's National Provider Identifier (NPI) is 1295929511, issued by NPPES.
Does Dr. Arshad Khanani accept Medicare assignment?
Yes. Dr. Arshad Khanani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Arshad Khanani commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, ranibizumab, 0.1 mg (HCPCS J2778). Source: CMS Medicare Physician & Other Practitioners file.